Bafna Pharmaceuticals Ltd

532989 Momentum

Summary

Fair Value Assessment
Momentum
Undervalued (24% Discount)
Fair ValueQ106.01UncertaintyHigh
Close Price80.00Mar 25, 2025
Market Closed
77.00
Price Down by 3.00 | 3.75 %
Previous Close
80.00
Day Range
77.00 – 80.00
Year Range
67.80 – 112.20
Bid / Ask
Market Cap
1.8 Bil
Volume / Average
351.0 / 957.3
Beta (5-Year)
0.59
Shares Outstanding
23.66 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Bafna Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in the manufacturing and marketing of drugs and medicines. The company sells its products in India and international regions. The company has only one Segment of Business namely Pharmaceuticals.
Contact
Thambu Chetty Street New No. 68, Old No.299, Bafna Towers, Chennai, TN 600001
T +91 4425267517
www.bafnapharma.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
363

Key Metrics

Income Statement (in Mil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
1,481.95 1,524.66 1,153.50 851.40 712.18 424.73
Revenue Growth %
-3.34% 32.18% 35.48% 19.55% 67.68% -2.65%
Gross Profit
434.78 455.59 387.56 338.55 257.62 154.49
Gross Profit Margin %
29.34% 29.88% 33.60% 39.76% 36.17% 36.37%
Operating Income
62.91 74.00 120.68 64.35 61.38 -19.61
Operating Margin %
4.25% 4.85% 10.46% 7.56% 8.62% -4.62%
EBIT
64.04 91.60 133.69 77.87 58.76 -19.22
EBIT Margin %
4.32% 6.01% 11.59% 9.15% 8.25% -4.52%
EBITDA
123.50 141.56 187.04 132.81 103.54 13.45
EBITDA Margin %
8.33% 9.28% 16.21% 15.60% 14.54% 3.17%
Net Income
42.97 73.48 113.38 51.51 58.27 -247.29
Net Profit Margin %
2.90% 4.82% 9.83% 8.58% 8.18% -4.43%
Basic EPS
1.82 3.11 4.79 2.17 2.46 -15.52
Diluted EPS
1.82 3.11 4.79 2.17 2.46 -15.52
Normalized EPS
Total Dividends per Share
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
1,341.60 1,476.82 1,295.83 902.44 864.66 713.13
Total Liabilities
514.09 668.43 561.29 273.64 296.95 201.17
Total Debt
188.23 243.89 229.24 90.43 157.86 30.18
Total Equity
827.51 808.39 734.55 628.80 567.71 511.95
Cash And Cash Equivalents
13.15 13.96 66.63 0.19 7.48 81.85
Working Capital
366.10 403.87 408.35 350.09 253.60 189.96
Shares Outstanding (Mil)
23.66 23.66
Book Value Per Share
34.17 31.05 26.58 24.00 21.61
Total Debt To Equity
0.23 0.30 0.31 0.14 0.28 0.06
Cash Flow Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
142.74 94.85 49.53 80.32 -136.09 -343.09
Cash From Investing Activities
-204.08 -150.54 -74.93 -54.39 -53.45 327.75
Cash From Financing Activities
-4.15 -8.45 101.77 -42.24 122.80 73.01
Capital Expenditures
158.48 82.19 75.41 60.95 14.29
Free Cash Flow
-33.95 96.20 9.77 34.61 -228.60
Change in Cash
-65.49 -64.14 76.37 -16.31 -66.75 57.68

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top